The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

about

RNAi screening identifies a mechanosensitive ROCK-JAK2-STAT3 network central to myofibroblast activation.Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment

P2860

Q52573450-5E9FBF3B-8975-4FDF-9766-941FC4638D28 Q58799997-633F16B9-F1D0-4571-9875-5B9AEDFAD1CB

P2860

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

Item

http://www.wikidata.org/entity/Q48509995

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@en

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@nl

type

Item

label

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@en

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@nl

prefLabel

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@en

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

@nl

P1476

The JAK2 pathway is activated in idiopathic pulmonary fibrosis

@en

P2093

Anselm Morell

http://www.w3.org/2001/XMLSchema#string

Beatriz Ballester

http://www.w3.org/2001/XMLSchema#string

Gracia Hernandez

http://www.w3.org/2001/XMLSchema#string

Inés Roger

http://www.w3.org/2001/XMLSchema#string

Javier Milara

http://www.w3.org/2001/XMLSchema#string

José M Lloris

http://www.w3.org/2001/XMLSchema#string

Juan Escrivá

http://www.w3.org/2001/XMLSchema#string

Julio Cortijo

http://www.w3.org/2001/XMLSchema#string

P Montero

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation

Novel high-throughput screening system for identifying STAT3-SH2 antagonists.

Identification of a novel inhibitor of JAK2 tyrosine kinase by structure-based virtual screening

Pathogenesis of idiopathic pulmonary fibrosis

Janus kinases: components of multiple signaling pathways.

Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice.

IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures.

Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway

Phosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cells.

JAK/STAT signal transduction: regulators and implication in hematological malignancies.

P2888

s12931-018-0728-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12931-018-0728-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Esteban Morcillo

María Molina-Molina

P577

2018-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100859680

http://www.w3.org/2001/XMLSchema#string

P698

29409529

http://www.w3.org/2001/XMLSchema#string

P921

pulmonary fibrosis

P932

5801676

http://www.w3.org/2001/XMLSchema#string

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

about

P2860

P2860

The JAK2 pathway is activated in idiopathic pulmonary fibrosis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932